Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
The brain’s function and integrity emerge not only from properties of individual regions, but, more fundamentally, from the intricate web of connections ...
Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...
CBSE has clarified that no corrections in LOC data will be allowed after the deadline. The Central Board of Secondary Education (CBSE) has issued a circular urging schools, parents, and students to ...
NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today unveiled visionary new products, strengthening its enterprise-grade data platform for AI innovation. As the era of AI shifts ...
Facepalm: Plenty of people are guilty of not backing up their data, but one would expect a government facility to have numerous copies of its information. The National Information Resources Service ...
Three scientists won the Nobel Prize in Chemistry for creating a new type of molecular structure that has been used to extract carbon dioxide from the air and separate pollutants from water. The ...
At the start of the year, a lesser-known infrastructure company called Aligned Data Centers managed to pull off a $12 billion fundraise — more than some of the world’s leading artificial intelligence ...
A group of young New Yorkers is receiving $12,000 in cryptocurrency as part of a new guaranteed-income experiment backed by Coinbase. The program, called Future First, selected 160 residents between ...
XRP surged to fresh highs after Japan’s SBI unveiled an institutional lending initiative, igniting volumes above 160M and lifting price through key resistance. Buyers defended $2.93 multiple times as ...
The Environmental Protection Agency announced earlier this month that it would stop making polluting companies report their greenhouse gas emissions to it, eliminating a crucial tool the US uses to ...
Data support the potential therapeutic efficacy of ROC-101; justify further development via a Phase 2, proof-of-concept trial in patients with PAH or ILD-PH slated to begin Q4 2025 NATICK, Mass., Sept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results